On June 25^th – 26^th Inovotion will be joining forces with industrials and academics who develop cancer fighting antibodies

Arnaud Peyronnier, Inovotion’s Sales Director, will be on hand at the 6^th AIS to make the case for Inovotion’s innovative approach when used for IO drugs and ADC, and show that our model is pertinent for screening potentially therapeutic antibodies.

The 300+ participants at this significant European event are all focused on developing new therapeutic approaches using antibodies. Inovotion has highly effective, rapid and affordable responses to the issues surrounding target selection discovery and validation.

Join Inovotion in the sunny South of France!